Ads
related to: Novavax
Search results
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 6 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Novavax (NASDAQ:NVAX) Trading 3.4% Higher
ETF DAILY NEWS· 2 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) shot up 3.4% during trading on Wednesday . 1,132,956 shares changed hands during trading, a decline of 90% from the average session ...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 4 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via AOL· 6 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
Shah Capital ends campaign against Novavax board after Sanofi deal By Reuters
Investing.com· 6 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 2 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX)
ETF DAILY NEWS· 3 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Novavax has a 1 year low of $3.53 and ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters· 2 days ago, opens new tab will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant that was dominant ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 7 days agoVaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months...